Skip to main content
MGX logo

MGX · Metagenomi Therapeutics, Inc.

Track MGX — free
$1.17 -0.01 (-0.85%)
Market Cap
$44.95M
Shares
37.78M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

MGX Latest Reported Short Interest

FINRA reported 1,453,190 MGX shares sold short as of the August 14, 2026 settlement date, a decrease of 40,147 shares. Days to cover was 10.98 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent stock splits

MGX Short Interest Forecast

Equibles' model estimates 1,400,071 shares sold short for the August 31, 2026 settlement, -3.7% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 21
1,400,071 -3.7% vs reported
The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
58/100
Short interest 3.8% of shares — P66 Days to cover 11.0 — P91 Price vs VWAP -5.0% — P34 Short-volume trend -5.1% — P32 Short interest change -2.7% — P42 Worst FTD 0.02% of shares — P60

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 1,453,190 1,493,337 -40,147 10.98
2026-07-31 1,493,337 1,543,288 -49,951 10.08
2026-07-15 1,543,288 1,684,034 -140,746 6.49
2026-06-30 1,684,034 1,755,888 -71,854 11.64
2026-06-15 1,755,888 1,831,424 -75,536 11.43
2026-05-29 1,831,424 1,807,425 +23,999 9.20
2026-05-15 1,807,425 1,787,777 +19,648 10.07
2026-04-30 1,787,777 1,870,222 -82,445 9.89
2026-04-15 1,870,222 2,167,525 -297,303 10.91
2026-03-31 2,167,525 2,003,259 +164,266 10.15
2026-03-13 2,003,259 1,931,219 +72,040 6.18
2026-02-27 1,931,219 1,982,687 -51,468 12.09
2026-02-13 1,982,687 2,423,284 -440,597 6.45
2026-01-30 2,423,284 2,358,973 +64,311 9.71
2026-01-15 2,358,973 2,208,088 +150,885 8.60
2025-12-31 2,208,088 2,045,457 +162,631 6.15
2025-12-15 2,045,457 1,609,444 +436,013 5.24
2025-11-28 1,609,444 1,227,790 +381,654 4.46
2025-11-14 1,227,790 1,402,015 -174,225 2.49
2025-10-31 1,402,015 1,611,815 -209,800 1.41
2025-10-15 1,611,815 1,490,834 +120,981 1.82
2025-09-30 1,490,834 1,094,418 +396,416 1.82
2025-09-15 1,094,418 1,424,336 -329,918 6.95

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1785279 CUSIP 59102M104 13F (30d) 40 filings 40 filers Visit website Investor relations